Stock DNA
Pharmaceuticals & Biotechnology
JPY 2,222 Million (Micro Cap)
185.00
NA
0.00%
0.10
11.16%
1.43
Revenue and Profits:
Net Sales:
904 Million
(Quarterly Results - Jun 2025)
Net Profit:
135 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.14%
0%
-12.14%
6 Months
19.08%
0%
19.08%
1 Year
39.23%
0%
39.23%
2 Years
-9.5%
0%
-9.5%
3 Years
-9.5%
0%
-9.5%
4 Years
-38.85%
0%
-38.85%
5 Years
-43.96%
0%
-43.96%
Artra Group Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.18%
EBIT Growth (5y)
16.83%
EBIT to Interest (avg)
-12.20
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
1.55
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.24%
ROE (avg)
1.63%
Valuation key factors
Factor
Value
P/E Ratio
185
Industry P/E
Price to Book Value
1.10
EV to EBIT
139.50
EV to EBITDA
10.72
EV to Capital Employed
1.09
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.78%
ROE (Latest)
0.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
903.70
1,008.50
-10.39%
Operating Profit (PBDIT) excl Other Income
66.00
12.70
419.69%
Interest
3.50
3.40
2.94%
Exceptional Items
0.00
0.50
-100.00%
Consolidate Net Profit
135.30
-28.70
571.43%
Operating Profit Margin (Excl OI)
50.40%
-25.60%
7.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -10.39% vs -7.16% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 571.43% vs -1,095.83% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
4,234.40
4,497.60
-5.85%
Operating Profit (PBDIT) excl Other Income
160.00
191.30
-16.36%
Interest
13.70
14.60
-6.16%
Exceptional Items
-28.60
-20.10
-42.29%
Consolidate Net Profit
-36.70
54.00
-167.96%
Operating Profit Margin (Excl OI)
1.30%
11.40%
-1.01%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.85% vs -3.72% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -167.96% vs 2,471.43% in Dec 2023
About Artra Group Corp. 
Artra Group Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






